Model N’s Fall 2020 Release for Life Sciences: New Features Streamline Pricing, Operations, Compliance and Cloud Deployment
Summary
Model N’s latest release is particularly timely, given that life sciences companies are among the firms most impacted by the coronavirus pandemic and related supply chain issues, and are looking for solutions that will improve their business processes. As a leader of contracting and pricing solutions, Model N helps support life sciences companies’ ongoing efforts to develop, manufacture and bring to market supplies, diagnostics, therapies, and potential vaccines that are integral to the global fight against COVID-19. This new capability, incorporating Discount Reallocation Management analysis bundles, helps customers determine how calculation methodology changes impact government pricing. Key new features for driving compliance include Medicaid advancements, incorporating functionality for Prior Quarter Adjustment Statement reporting and the CA Supplemental Program. Model N empowers its customers to fully optimize business operations and maximize revenue, even in an environment made notably more uncertain and unpredictable due to the COVID-19 pandemic.
Classifications
AskAI Classifications
LabelsLinked Companies
